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Abstract
Background: To determine the prevalence of hypertension treatment and control among hypertensive patients in
the Cuban municipalities of Cardenas and Santiago and to explore the main associated predictors.
Methods: Cross-sectional study, with multistage cluster sampling, conducted between February 2012 and January
2013 in two Cuban municipalities. We interviewed and measured blood pressure in 1333 hypertensive patients
aged 18 years or older. Hypertension control was defined as blood pressure lower than 140/90 mmHg.
Results: The mean age ± standard deviation (SD) of participants was 59.8 ± 14 years, the mean systolic and diastolic
blood pressure ± SD was 130.0 ± 14.4 and 83.1 ± 9.0 mmHg respectively. The majority of patients (91, 95%CI 90–93)
were on pharmacological treatment, 49% with a combination of 2 or more classes of drugs. Among diagnosed
hypertensive patients 58% (95%CI 55–61) had controlled hypertension. There was no association between
hypertension control and gender, age and socio-economic condition. Levels of hypertension control depended on
health area and control furthermore was positively associated with post-primary education, not being obese and
white ethnicity: adjusted Odds Ratio (95% CI) 1.71 (1.26–2.34), 1.43 (1.09–1.88) and 1.41 (1.09–1.81) respectively.
Conclusions: The observed figures are outstanding at the international level and illustrate that hypertension
treatment and control are achievable in a resource-constrained setting such as Cuba. The country’s primary
health care approach and social equity in access to health care can be seen as key determinants of this
success. Nevertheless, there is still room for improvement, as over a third of patients did not have controlled
hypertension.
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Background
Non-communicable diseases (NCDs) account for 63% of
global mortality nowadays and it is predicted that they
will account for 69% of global deaths by 2030 [1]. They
are significantly related to preventable early mortality
and disability and they are especially worrying for devel-
oping countries, where their incidence is increasing dis-
proportionately. According to the Pan American Health
Organization, non-communicable diseases are the first
cause of death and disability in the Americas region,
generating almost 4 million deaths annually [2].
Cardiovascular diseases (CVD) are the leading cause of
death around the world and uncontrolled hypertension
is a related cause of 7.6 million deaths each year [3]. Fur-
thermore, approximately 51% of deaths due to stroke
and 45% of deaths due to ischaemic heart disease are at-
tributable to systolic hypertension. The risk of dying
from hypertension at all ages is more than double in low
and middle income countries (LMIC) compared to high
income countries (HIC) [4].
Notwithstanding, the majority of health systems pro-
vide inadequate chronic diseases management, with
health services mainly designed to provide acute curative
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care. This global trend has been termed “the tyranny of
the urgent” [5]. Chronic care, especially in developing
countries, is often reduced to the belated management
of acute exacerbations of chronic illnesses in specialized
settings and at high costs. Not surprisingly, most
out-of-pocket health payments and catastrophic expend-
iture are related to chronic conditions, in particular
especially to costly but avoidable complications such as
kidney failure, heart attack and stroke [6–8].
Cuba went through an epidemiological transition from
the mid-twentieth century onwards. Today, chronic dis-
eases account for 86% of total deaths in the country and
CVD are responsible for 39% of the overall mortality [9].
In 2013, the death rate from CVD was 202.9 per 100.000
population [10], while in the latest nationwide survey
hypertension prevalence was estimated at 30.9% of the
population above 15 years [11]. The ongoing process of
urbanization and lifestyle changes contributes to a fur-
ther increasing burden of CVD [12].
Cuba is internationally recognized for having a
well-organized national health system based on a pri-
mary health care (PHC) approach and it can be consid-
ered an excellent setting to study the potential of
low-resource health systems to develop comprehensive
programs for chronic care. The Cuban health system not
only has achieved excellent control of communicable
diseases but also presented one of the best hypertension
control figures in the world [13]. Nevertheless, there re-
main problems with regard to quality and long-term
continuity of care provided for chronic patients. The last
internationally published study on hypertension control
in the country, carried out in the Cienfuegos province in
2001–2002, reported a control rate of 62% among
treated hypertensive patients [13]. Since then, Cuba ex-
perienced socioeconomic and political changes, possibly
affecting population’s health. More than a decade after
the latest report, an update is needed.
The present study primarily aims at determining the
current proportion of treated and controlled hyperten-
sive patients in two different geographical areas of the
country (Cardenas and Santiago municipalities). More-
over, predictors associated with achieving hypertension
control were explored.
Methods
This cross-sectional study was conducted between Feb-
ruary 2012 and January 2013 in the Cuban municipal-
ities of Cardenas and Santiago (total population in 2012:
142.369 and 513.784 respectively) [14]. Health areas in
the Cuban PHC system consist of family doctor/nurse
practices (FDNP) and policlinics. FDNP take responsibil-
ity for population health and are in charge of carrying
out individual and community risk assessment [15].
They are the first entry point to the health care system.
Policlinics provide diagnostic and support services to
FDNP and specialized care. A health area is comprised
of one policlinic and around 30 FDNP and counts ap-
proximately 30.000 inhabitants. The entire population is
registered with a FDNP.
The study municipalities and the health areas within
each municipality were purposively selected on the basis
of feasibility and the commitment of local health author-
ities to carry out the study and to implement subse-
quently interventions for quality improvement of the
hypertension management program. In each municipal-
ity, two urban health areas were selected: “Julio Antonio
Echeverria (JAE)” and “Moncada” in Cardenas and “Gri-
mau” and “Finlay” in Santiago. In each health area, 14
FDNP were randomly selected. In each of these FDNP,
25 hypertensive patients were selected by simple random
sampling from the family doctor register. Patients were
included if they were aged 18 years or older, had a con-
firmed diagnosis of hypertension documented in their
medical records and provided their written informed
consent. Thus, a total of 1400 hypertensive patients were
sampled (700 per municipality, 350 per health area),
allowing to estimate the proportion of patients with con-
trolled hypertension (anticipated to be at least 50%) with
a confidence level of 95%, a precision of 5% and a cluster
effect of 2.5.
Data collection was done by a group of junior re-
searchers of the Cuban National Institute of Hygiene
and Epidemiology (INHEM). In order to guarantee reli-
ability and consistency, they received a 3 days training at
INHEM and had to pass a standardized test on blood
pressure measurement. Door to door visits in the homes
of the selected patients, during which blood pressure
measurement and interviews were carried out, were
made by research staff. In case the person was not found
at home, two further visits were made before another
patient was selected. Blood pressure was measured three
times, from the right arm in a sitting posture, using a
mercury manometer, following international standard-
ized recommendations for blood pressure measurement
in population surveys [16, 17]. The mean of the last two
readings was calculated and hypertension was defined as
controlled if the mean systolic and diastolic blood pres-
sure were respectively lower than 140 and 90mmHg. All
participants were interviewed on their previous and
current health problems, anti-hypertensive pharmaco-
logical treatment and health seeking behaviour using a
structured questionnaire. The main variables measured
during the survey were assessed by self-report: ethnicity
(white / non-white, comprising mestizo and black);
post-primary education (yes: university, technical college
or secondary school / no: did not finish secondary
school); paid job (yes: state worker, self-employed / no:
housewife, student, unemployed and retired); medical
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history of diabetes (yes / no); medical history of heart
disease (yes / no). To determine levels of adherence to
pharmacological treatment, we applied the four-item
Medication Adherence Questionnaire (MAQ) by Mor-
isky et al. [18].
Participants’ weight and height were also measured.
Body weight was measured to ±0.1 kg using electronic
scales, standing height was measured to ± 0.01m using a
wall mounted stadiometer and body-mass index (BMI)
was calculated as weight/height2 (kg/m2). Based on Word
Health Organization criteria [19, 20] nutritional status was
classified on the basis of BMI: underweight: below 18.5;
normal weight: 18.5–24.9; overweight: 25–29.9; obesity:
≥30. BMI was dichotomised as obese/non-obese for fur-
ther analysis.
Data were double-entered in a Microsoft Access 2000
database and analysed using the Statistical Package for
Social Sciences (SPSS) V.23 (SPSS Inc., Chicago, IL,
USA). Means and standard deviations and proportions
with 95% confidence intervals (95%CI) were calculated
for continuous and categorical variables respectively.
The association between hypertension control and
socio-demographic and clinical factors was explored
using the Chi-squared and the t test for categorical and
continuous variables respectively. P values less than 0.05
were considered significant. Potential predictors for con-
trolled hypertension were included in a multivariate lo-
gistic regression model if they were statically significant
in bivariate analysis (conservatively taking p < 0.1 as
threshold) or a priori considered of relevance.
Unadjusted and adjusted Odds Ratios (ORs) and their
95%CI were calculated, taking into account the clus-
tered/multistage study design.
Results
Sixty-seven sampled patients (5%), mostly from JAE
health area, were not found at home after 3 visits but
were not replaced due to operational constraints. Hence,
the total number of respondents was 1333 (Table 1).
There was a higher percentage of women, especially in
the health areas of Santiago. The mean age of partici-
pants was 59.8 years and females were older than males
(61.2 vs 58.0 years, p < 0.001). Based on self-report, 43%
of the sample was white, 29% mestizo and 28% black.
High levels of health care utilization were observed: 42%
of patients had a contact during the 3 months before the
survey; 71% (95% CI, 68–74%) of these contacts were
with first-line health services. The mean blood pressure
in the study population was 130.0/83.0 mmHg. Con-
trolled hypertension was found in 773 patients (58,
95%CI 55–61) (Table 1). The majority of respondents
(91%) reported receiving anti-hypertensive pharmaco-
logical treatment. Among those taking medication 49%
(95% CI, 46–52) were fully complying with the
treatment. The mean BMI ± SD was 26.5 ± 4.6. The most
frequently used classes of drugs were
angiotensin-converting enzyme inhibitors/angiotensin II
receptor blockers (ACEi/ARB), followed by diuretics,
beta-blockers and calcium channel blockers (CCB)
(Fig. 1). Overall, 49% (95%CI 46–52) of patients receiv-
ing treatment were taking a combination of two or more
classes of drugs. Diuretics plus ACE/ARB was the most
frequently used combination (49, 95%CI 45–53),
followed by diuretics plus beta blockers (13, 95%CI 11–
16) and diuretics plus CCB (11, 95%CI 9–14) (Fig. 2).
Table 2. The proportion of patients with hypertension
control was significantly higher in individuals with
post-primary education, that were non-obese and had
white ethnicity. Given the results of bivariate analysis,
which showed that the percentage of patients with con-
trolled hypertension among underweight, normal weight
and overweight individuals was similar: respectively 59%
(16/27), 60% (308/518) and 60% (315/523) against 51%
(134/265) in obese individuals, BMI was dichotomised as
obese/non-obese. Municipality was not related to hyper-
tension control (59% in Cárdenas, 57% in Santiago, p =
0.44) but levels of hypertension control depended on
health area. Gender, age, civil status, labour activity, re-
ceiving anti-hypertensive drugs, compliance with
pharmacological treatment and personal history of cor-
onary heart disease or diabetes were not significantly as-
sociated with hypertension control. Among the 115 not
receiving treatment 55% (95% CI, 46–64) had controlled
hypertension. In multivariate analysis, the variables
which exerted significant influence on hypertension con-
trol were: post-primary education, obesity and white eth-
nicity (Table 2).
Discussion
This study found a high prevalence of pharmacological
treatment and blood pressure control among diagnosed
hypertensive patients in two Cuban municipalities. Al-
most half of patients receiving treatment were taking
two or more antihypertensive drugs. Hypertension con-
trol varied by health area within a municipality. Having
post-primary education, not being obese and being of
white ethnicity were positively associated with hyperten-
sion control.
Given that in Cuba the entire population is registered
with a FDNP, who must carry out an individual risk as-
sessment of the recorded population on a yearly basis,
registers of patients provided by the Ministry of Health
reflect the actual population’s health status. This is cor-
roborated by the findings of the Third National Survey
on Risk Factors in Cuba 2010–2011 where the preva-
lence of diagnosed hypertensive patients in the popula-
tion above 15 years (2010) was 22.4% vs 20.4% found in
the Ministry of Health registers [11]. The study
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population consisted of a sample drawn from two of the
168 Cuban municipalities and thus it may not represent
the national situation, in particular with respect to rural
areas. Nevertheless, the found prevalence figures are
consistent with national surveys [11] and an earlier simi-
lar study in the Cuban province of Cienfuegos [13]. In
order to minimize errors, international standardized rec-
ommendations for blood pressure measurement in
population surveys were followed [16, 17]. However,
blood pressure control was measured in a single visit,
with the possibility of some false-positive uncontrolled
hypertensive patients, resulting in an underestimation of
hypertension control. Except for obesity, presence of co-
morbidities was self-reported without confirmation on
clinical records or with diagnostic tests, which can be a
limitation for their analysis as predictors. The use of
self-report scales for measuring medication adherence
also has potential limitations, especially regarding pa-
tients’ ability to understand the items and willingness to
disclose information, which can affect questionnaire
validity [21]. Moreover, the 4-item Morisky MAQ [18] is
only able to address barriers to medication-taking but
not self-efficacy [21, 22]. Nevertheless, this test, validated
in the USA with hypertensive patients, presented a rea-
sonable specificity in identifying non-adherent behaviour
[23]. Another limitation is that factors such as smoking
status, duration of hypertension or lipid profile, which
besides being etiologically related to hypertension could
also be associated with its control, were not included in
the study.
The high prevalence of hypertension treatment and
control among diagnosed patients found in this study is
consistent with a previous study carried out in the
Cuban province of Cienfuegos in 2001–2002 [13], sug-
gesting more than a decade of sustainable outcomes.
The recent PURE study [3] found an average prevalence
of hypertension control among diagnosed patients re-
ceiving treatment of 41% in HIC and 27% in LMIC.
Hence, the prevalence of hypertension control in Cuba
found in the present study (58%) is considerably higher
Fig. 1 Prevalence of use of main classes of anti-hypertensive drugs. Cardenas and Santiago municipalities, Cuba, 2012–2013. Error bars represent
the 95% confidence intervals. ACEi/ARB = Angiotensin Converting Enzyme inhibitor / Angiotensin II Receptor Blocker; B-Blocker = Beta-blocker.;
CCB = Calcium Channel Blocker
Fig. 2 Prevalence of use of different anti-hypertensive drug combinations. Cardenas and Santiago municipalities, Cuba, 2012–2013. Error bars
represent the 95% confidence intervals. ACEi/ARB = Angiotensin Converting Enzyme inhibitor / Angiotensin II Receptor Blocker; B-Blocker = Beta-
blocker.; CCB = Calcium Channel Blocker
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than the average in HIC and double that of LMIC. The
figure is similar to what found in the Health Survey for
England 2015, where 62% of treated patients had their
blood pressure under control [24]. A study comparing
hypertension management in 20 countries among both
aware and unaware systolic hypertensive patients, reports
that the United States had the best age-standardized
prevalence of systolic hypertension treatment and control
in patients aged 35 to 84 years (81% for treatment and
59% for control) followed by Jordan (71 and 38%) and
England (54 and 32%) [25]. Due to the heterogeneity of
methods among different studies, conclusions based on
Table 2 Predictors of controlled hypertension among hypertensive patients in the municipalities of Cardenas and Santiago, Cuba,
2012–2013
Predictor Controlled hypertension, No. (%) Unadjusted OR
(95% CI)
Adjusted OR
(95%CI)No Yes
Sex
Male 224 (44) 290 (56) Reference –
Female 336 (41) 483 (59) 1.11 (0.89–1.39)
Age in years
< 65 332 (41) 475 (59) 1.10 (0.88–1.37) –
≥ 65 228 (43) 298 (58) Reference
Ethnicity
Non-white 338 (45) 420 (55) Reference Ref.
White 222 (39) 353 (61) 1.28 (1.03–1.59) 1.39 (1.08–1.79)
Post-primary Education
No 109 (53) 96 (47) Reference Ref.
Yes 451 (40) 677 (60) 1.70 (1.26–2.30) 1.72 (1.26–2.35)
Civil status
Single 241 (42) 330 (58) Reference –
Married/Partner 319 (42) 443 (58) 1.01 (0.81–1.26)
Paid job
No 222 (43) 300 (58) Reference –
Yes 338 (42) 473 (58) 0.97 (0.77–1.20)
Obesity
Yes 131 (49) 134 (51) Reference Ref.
No 429 (40) 639 (60) 1.46 (1.11–1.91) 1.43 (1.09–1.89)
Diabetes
Yes 89 (43) 118 (57) Reference –
No 471 (42) 655 (58) 1.05 (0.78–1.42)
Coronary heart disease
Yes 79 (43) 106 (57) Reference –
No 481 (42) 667 (58) 1.03 (0.75–1.42)
On anti-hypertensive pharmacological treatment
===No 52 (45) 63 (55) Reference Ref.
Yes, non-adherent 281 (45) 341 (55) 1.00 (0.7–1.5) 1.06 (0.70–1.59)
Yes, adherent 227 (38) 369 (62) 1.34 (0.90–2.0) 1.35 (0.90–2.05)
Health area
JAE 101 (35) 191 (65) Reference Ref.
Finlay 164 (47) 187 (53) 0.60 (0.45–0.81) 0.75 (0.54–1.04)
Grimau 135 (39) 209 (61) 0.82 (0.60–1.11) 1.11 (0.78–1.56)
Moncada 160 (46) 186 (54) 0.62 (0.46–0.83) 0.71 (0.52–0.98)
CI confidence interval, JAE José Antonio Echeverría
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such comparisons should be interpreted with caution.
Notwithstanding internationally outstanding figures, still
more than a third of hypertensive patients did not have
controlled hypertension, which warrants the attention of
the Cuban health authorities.
Hypertension control at population level has been for-
warded as a correlate measure of how well a health system
functions, given that this condition is entirely dependent
on the health system for its care and control [26]. Con-
strains to provide integrated and quality chronic care have
been associated with weak national health systems and
fragmented health-care services [1, 27, 28]. For instance,
in Sub-Saharan Africa, a region characterized by weak
health systems, hypertension remains largely
under-diagnosed and under-treated [26]. From a health
system perspective, at least three key drivers of successful
hypertension control in Cuba can be identified. First and
foremost, a PHC approach: Cuba, despite being a
resource-constrained setting, ensures free and accessible
quality care through FDNP [15] and is recognized for hav-
ing a well-organized national health system that ensures
inter-sectorial actions to promote health and wellbeing
[12, 13, 29]. As underlined by the European Forum for
Primary Care, a strong PHC system is better prepared to
provide comprehensive health care and effectively
co-ordinate the follow-up of chronic conditions [30]. Be-
sides Cuba, two other Latin-American countries, Brazil
and Costa Rica, provide evidence of the effectiveness, effi-
ciency and relevance of the PHC approach for the man-
agement of chronic conditions [28, 31–33]. Second, the
high percentage of patients receiving pharmacological
treatment found in this study confirms the reported avail-
ability, proper procurement and distribution of essential
anti-hypertensive drugs in Cuba [29]. Third, Cuba has one
of the highest densities of physicians in the world: 67.2 per
10,000 population, only surpassed by rich countries such
as Monaco and Qatar [34]. Moreover, family doctors in
charge of PHC services are specialists, with at least 3 years
of postgraduate training [15]. In summary, the main
health system barriers to achieve blood-pressure control
pinpointed by Ibrahim and Damasceno (namely scarce
human resources, absence of a national policy for the con-
trol of NCDs, poor training of health personnel, overbur-
dened and disorganized PHC and a deficient procurement
and distribution of essential antihypertensive drugs) [35],
have been overcome in the Cuban health system. Notwith-
standing, the association of hypertension control with liv-
ing in a specific health area suggests that hypertension
control could be impacted at community level by improv-
ing health services functioning at micro-level.
Appropriate drug titration and combination therapies
are also key elements for achieving hypertension control.
According to international guidelines, more than
two-thirds of hypertensive patients require treatment
with more than one antihypertensive drug to achieve
blood pressure control [3, 36, 37]. The proportion of pa-
tients taking two or more types of antihypertensive
drugs found in this study (49%) was high compared to
average international figs. [3], suggesting that clinical in-
ertia is not an important barrier affecting adequate anti-
hypertensive therapy in Cuba. Overall, the combinations
of antihypertensive drugs found in this study are aligned
with international guidelines [36, 37]. Moreover, the type
and frequency of medications used are more similar to
the pattern reported in HIC than in LMIC [3]. Neverthe-
less, recent evidence showed that B-blockers are inferior
to other drugs for the prevention of major CVD, stroke
and renal failure [38] and they were not recommended
by the Eight Joint National Committee for the initial
treatment of hypertension [37]. Therefore, Cuban health
authorities should take appropriate measures to address
the high use of B-blockers and decrease their prescrip-
tion, especially as monotherapy or initial treatment.
Being on pharmacological treatment was not significantly
associated with hypertension control, but the vast majority
of patients were on pharmacological treatment and control
in other hypertensive may have been achieved by lifestyle
modifications, which were not explored in depth in the
present study. International literature widely describes the
positive effects that sustained lifestyle modifications such as
weight loss, diets rich in fruits/vegetables, and sodium (Na
+) reduction have on blood pressure (BP) control [39].
Other non-pharmacological strategies recommended for
patients with hypertension include tobacco cessation, de-
creased alcohol consumption and self-measured BP moni-
toring [40]. However, this study, did not explore the effect
of non-pharmacological approaches to blood pressure con-
trol. Pharmacological treatment and adherence to it was in-
cluded in the final multivariate model, but the difference
between the individual categories was not significant. This
could possibly be explained by inherent limitations of the
Morisky test for capturing actual adherence, which have
been signaled before.
The lack of association of hypertension control with
age, gender and socio-economic conditions could be ex-
plained by the equity in access to health care services in
Cuba irrespective of gender or social condition, where
all adults receive at least one home visit of their family
doctor/nurse per year, a frequency that increases accord-
ing to specific risk profiles or disabilities [12]. The asso-
ciation between post-primary education and better
hypertension control is consistent with other national
and international reports [11, 41–44]. Furthermore, the
high prevalence of post-primary education found in the
study population (85%), is a significant factor related to
achieving hypertension control in Cuba, as a higher edu-
cation level is relevant for disease awareness and compli-
ance to treatment [45, 46].
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Obesity was found to be associated with poorer hyper-
tension control. This is compatible with available evidence
reporting a stable linear relation between adiposity and
blood pressure, independent of age and body fat distribu-
tion [35]. High BMI alone is a very well established risk
factor for hypertension and obese individuals have in-
creased relative risk for CVD [36]. Obesity is a serious
concern indeed for Cuba: in 2011, 45% of the Cuban
population was overweight and 15% was obese [11].
In this study non-white hypertensive patients (mestizo
or black) were more likely to have uncontrolled hyperten-
sion, regardless of socio-economic condition. Differences
associated with ethnicity could be related to lifestyle differ-
ences or to genetic factors such salt sensitivity, which is
more common in black people [35]. There are no specific
studies on hypertension and cardiovascular complications
among black communities in the Latin American and
Caribbean region [47]. Studies done in United States
showed that hypertension is more common, severe and
leads to more clinical sequelae in African Americans com-
pared to non-Hispanic whites [36]. Nevertheless, since Af-
rican Americans also have a greater prevalence of other
cardiovascular risk factors, hypertension has been mainly
attributed to environmental and lifestyle factors and
socio-economic condition rather that to genetically de-
fined racial differences [35, 36].
Lowering blood pressure significantly reduces the risk of
major cardiovascular events and all-cause mortality [38]
and hypertension control at population level should be of
the highest priority in all countries. Evidence also indicates
that only well-functioning health systems are able to ad-
dress NCDs effectively and equitably [48]. Based on the
results reported here, a set of interventions - at health ser-
vice and community level - aimed at increasing the effect-
iveness of hypertension management programs in both
municipalities will be designed, implemented and
evaluated.
Conclusions
While there is still room for improvement, the figures ob-
served in this study are outstanding at the international
level and illustrate that hypertension treatment and con-
trol is achievable in a resource-constrained setting such as
Cuba. The country’s primary health care approach and so-
cial equity in access to care can be seen as key to over-
come system barriers to blood-pressure control and
sustained clinical outcomes. This may inspire policy
makers in other developing countries to adapt their public
health systems’ set up and functioning to respond to the
growing need for better chronic care.
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